Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for primary pulmonary tuberculosis.
9 publications have been identified in PubMed for primary pulmonary tuberculosis. Research spans Case Report / Case Series (75%), Other (13%), and Basic Science / Preclinical (13%).
Yabaji SM (2025). [PMID: 40714561](https://pubmed.ncbi.nlm.nih.gov/40714561/). *STAR protocols*. [Case Report / Case Series]
Majozini L (2025). [PMID: 40612284](https://pubmed.ncbi.nlm.nih.gov/40612284/). *SA journal of radiology*. [Case Report / Case Series]
Hong W (2024). [PMID: 39434174](https://pubmed.ncbi.nlm.nih.gov/39434174/). *Journal of medical case reports*. [Case Report / Case Series]
Yadav S (2024). [PMID: 38978944](https://pubmed.ncbi.nlm.nih.gov/38978944/). *Cureus*. [Other]
Saha S (2024). [PMID: 38983429](https://pubmed.ncbi.nlm.nih.gov/38983429/). *World journal of clinical cases*. [Case Report / Case Series]
Sabzi F (2024). [PMID: 39351480](https://pubmed.ncbi.nlm.nih.gov/39351480/). *Global cardiology science & practice*. [Basic Science / Preclinical]
Benchafai I (2024). [PMID: 39449913](https://pubmed.ncbi.nlm.nih.gov/39449913/). *Cureus*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
European rare disease database
Chen Y (2024). [PMID: 39312323](https://pubmed.ncbi.nlm.nih.gov/39312323/). *Medicine*. [Case Report / Case Series]
AI-curated news mentioning primary pulmonary tuberculosis
Updated Jul 31, 2026
A case report highlights the potential of immune checkpoint inhibitor rechallenge following pazopanib treatment in a patient with primary pulmonary angiosarcoma. This study contributes to the understanding of treatment strategies for this rare cancer.
Recent research highlights pathological advances and clinical management insights into primary pulmonary myxoid sarcoma associated with the rare EWSR1::CREB1 fusion. This study provides valuable information for understanding this rare tumor's characteristics and potential treatment strategies.
FDA has released final guidance to assist sponsors in developing new antibacterial drugs for pulmonary tuberculosis treatment. This guidance finalizes the draft issued in December 2022, aiming to streamline the clinical development process for TB therapies.
A clinicopathological analysis of 40 cases of primary pulmonary epithelioid hemangioendothelioma has been published, providing insights into the disease's characteristics and behavior. This research contributes to the understanding of this rare vascular tumor.